Bing Zhao
Corporate Officer/Principal chez H&J Cro International, Inc. /CN/
Profil
Bing Zhao is currently the Director-Clinical Center at Rundo-Cronova Intl Pharms Research & Development Co., Ltd., Director-Clinical Center & Executive Vice GM at Guangzhou Osmunda Medical Device Technical Service Co., Ltd., and Director-Clinical Center & Vice President at H&J Cro International, Inc. Previously, he worked as Vice President-Clinical & Regulatory Affairs at Xynomic Pharmaceuticals Holdings, Inc. Dr. Zhao received his undergraduate, graduate, and doctorate degrees from Xi'an Jiaotong University Health Science Center.
Postes actifs de Bing Zhao
| Sociétés | Poste | Début |
|---|---|---|
| H&J Cro International, Inc. /CN/ | Corporate Officer/Principal | - |
| Rundo-Cronova Intl Pharms Research & Development Co., Ltd. | Corporate Officer/Principal | - |
Guangzhou Osmunda Medical Device Technical Service Co., Ltd.
 Guangzhou Osmunda Medical Device Technical Service Co., Ltd. Medical SpecialtiesHealth Technology Guangzhou Osmunda Medical Device Technical Service Co., Ltd. engages in providing service in the medical device field. The company was founded in February 2004 and is headquartered in Guangzhou, China. | Corporate Officer/Principal | - |
Anciens postes connus de Bing Zhao
| Sociétés | Poste | Fin |
|---|---|---|
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Bing Zhao
| Xi'an Jiaotong University Health Science Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
| Rundo-Cronova Intl Pharms Research & Development Co., Ltd. | |
Guangzhou Osmunda Medical Device Technical Service Co., Ltd.
Guangzhou Osmunda Medical Device Technical Service Co., Ltd. Medical SpecialtiesHealth Technology Guangzhou Osmunda Medical Device Technical Service Co., Ltd. engages in providing service in the medical device field. The company was founded in February 2004 and is headquartered in Guangzhou, China. | Health Technology |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
| H&J Cro International, Inc. /CN/ |
